LEADER 01465nam a2200337 u 4500
001 EB001840489
003 EBX01000000000000001004478
005 00000000000000.0
007 tu|||||||||||||||||||||
008 180702 r ||| eng
020 |a 9789283212706 
020 |a 9283212703 
245 0 0 |a Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8  |h Elektronische Ressource 
260 |a Lyon, France  |b IARC  |c 1997, 1997 
300 |a xiii, 524 p.  |b ill.  |c 25 cm 
505 0 |a Includes bibliographical references and cumulative index 
653 |a Tumor Virus Infections 
653 |a Herpesviridae Infections / complications 
653 |a Herpesvirus 4, Human 
653 |a Herpesvirus 8, Human 
653 |a Risk Assessment 
653 |a Lymphoma / etiology 
653 |a Nasopharyngeal Neoplasms / etiology 
710 2 |a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 
710 2 |a International Agency for Research on Cancer 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a IARC monographs on the evaluation of carcinogenic risks to humans 
500 |a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17-24 June 1997." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK385507  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 140